<SUBMISSION>
<ACCESSION-NUMBER>0000891618-03-002048
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20030424
<ITEMS>5
<ITEMS>9
<FILING-DATE>20030424
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>INTUITIVE SURGICAL INC
<CIK>0001035267
<ASSIGNED-SIC>3842
<IRS-NUMBER>770416458
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-30713
<FILM-NUMBER>03662500
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1340 W MIDDLEFIELD ROAD
<CITY>MOUNTAIN VIEW
<STATE>CA
<ZIP>94043
<PHONE>6502377000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1340 W MIDDLEFIELD ROAD
<CITY>MOUNTAIN VIEW
<STATE>CA
<ZIP>94043
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f89501e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Intuitive Surgical, 8-K, 04/24/03</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="4"><B>UNITED STATES</B>
</FONT>

<DIV align="center"><FONT size="3"><B>SECURITIES AND EXCHANGE
COMMISSION<BR>
WASHINGTON, D.C. 20549</B>
</FONT>
</DIV>

<P align="center"><HR align="center" size="1" width="15%" noshade>

<P align="center"><FONT size="5"><B>FORM 8-K</B>
</FONT>

<P align="center"><FONT size="2"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>
</FONT>

<P align="center"><FONT size="2">Date of earliest event reported: April&nbsp;24, 2003
</FONT>

<P align="center"><FONT size="6">INTUITIVE SURGICAL, INC.
</FONT>

<DIV align="center"><FONT size="2"><HR align="center" size="1" width="50%" noshade>
(Exact Name of Registrant as Specified in Charter)
</FONT>
</DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="2">Delaware</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="2">000-30713</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="2">77-0416458</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">(State or Other
Jurisdiction of<BR>
Incorporation)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
(Commission File Number)
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">950 Kifer Road, Sunnyvale, California 94085
</FONT>

<DIV align="center"><FONT size="2"><HR align="center" size="1" width="30%" noshade>
(Address of Principal Executive Offices) (Zip Code)
</FONT>
</DIV>

<P align="center"><FONT size="2">(408)&nbsp;524-2100
</FONT>

<DIV align="center"><FONT size="2"><HR align="center" size="1" width="30%" noshade>
(Registrant&#146;s telephone number, including area code)
</FONT>
</DIV>

<P align="center"><HR align="center" size="1" width="40%" noshade>

<DIV align="center"><FONT size="2">(Former Name or Former Address, if Changed Since Last Report)
</FONT>
</DIV>

<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">ITEM 9. REGULATION FD DISCLOSURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="f89501exv99w1.txt">EXHIBIT 99.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<!-- link2 "ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE" -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="left"><FONT size="2"><B>ITEM 5.</B>&nbsp;&nbsp;&nbsp;<B>OTHER EVENTS AND REQUIRED FD DISCLOSURE</B>
</FONT>

<P align="left"><FONT size="2">Patent Infringement Litigation</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As previously disclosed, on September&nbsp;1, 2000 Brookhill-Wilk 1, LLC
(&#147;Wilk&#148;) filed a lawsuit against Intuitive Surgical, Inc. (&#147;Intuitive
Surgical&#148;) in the United States District Court for the Southern District of New
York (Case No.&nbsp;00 Civ. 6599 (NRB)) alleging that by making, using, selling or
offering for sale its <I>da Vinci </I>Surgical System, Intuitive Surgical is
infringing U.S. Patent Nos. 5,217,003 and 5,368,015 in willful disregard of
Wilk&#146;s patent rights. These patents concern methods and devices for &#147;remote&#148;
surgery. In March 2001, Wilk withdrew its assertion of infringement of the 015
patent against Intuitive Surgical. On November&nbsp;8, 2001, in response to a
motion on one of Intuitive Surgical&#146;s noninfringement defenses, the District
Court granted summary judgment of noninfringement of the 003 patent in favor of
Intuitive Surgical and dismissed Wilk&#146;s complaint in its entirety without
prejudice. Wilk appealed the summary judgment ruling to the U.S. Court of
Appeals for the Federal Circuit.
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April&nbsp;11, 2003, the Court of Appeals reversed the District Court&#146;s
judgment and remanded the case for further proceedings. This reversal is based
on the Court of Appeals&#146; determination that the particular claim limitation at
issue should be interpreted differently than as construed by the District
Court. Nevertheless, Intuitive Surgical believes that the Court of Appeals&#146; opinion is not
necessarily inconsistent with the noninfringement defense initially
presented by Intuitive Surgical to the District Court and does not
impact Intuitive Surgical&#146;s other noninfringement defenses.
Intuitive Surgical expects to request clarification from the Court of
Appeals on the claim construction adopted before returning to the
District Court to continue to defend the claims relating to the 003
patent. Upon remand,
Intuitive Surgical intends to continue to vigorously defend its rights and, if necessary,
is prepared to continue to dispute the meaning of other portions of the
asserted claim language and to conduct discovery and file further motions on
whether the patent is infringed, valid and/or enforceable. Intuitive Surgical
believes that it will prevail in the litigation and that it has multiple
meritorious defenses to Wilk&#146;s allegations. However, litigation is
unpredictable and Intuitive Surgical may not prevail. The case remains in its
early stages of discovery.
</FONT>
<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For a discussion of the risks associated with this litigation, please see
Intuitive Surgical&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended
December&nbsp;31, 2002 and Registration Statement on Form&nbsp;S-4 (File No.&nbsp;333-104093)
filed with the Securities and Exchange Commission on March&nbsp;28, 2003.
</FONT>
<!-- link2 "ITEM 9. REGULATION FD DISCLOSURE" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="left"><FONT size="2"><B>ITEM 9.</B>&nbsp;&nbsp;&nbsp;<B>REGULATION FD DISCLOSURE</B>
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information contained in this Item&nbsp;9 is being furnished pursuant to
&#147;Item&nbsp;12. Results of Operations and Financial Condition&#148; of Form&nbsp;8-K in
accordance with SEC Release Nos. 33-8216 and 34-47583.
</FONT>
<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information, including Exhibit&nbsp;99.1 attached hereto, in this Item&nbsp;9 is
being furnished and shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18
of the Securities and Exchange Act of 1934, as amended, or otherwise subject to
the liabilities of that
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<P align="left"><FONT size="2"> Section. The information in this Item&nbsp;9 shall not be incorporated by
reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended, except as otherwise expressly stated in
such filing.
</FONT>
<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attached and incorporated by reference as Exhibit&nbsp;99.1 is a copy of the
press release of Intuitive Surgical, dated April&nbsp;24, 2003, reporting Intuitive
Surgical&#146;s financial results for the quarter ended March&nbsp;31, 2003.
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
INTUITIVE SURGICAL, INC.</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
By: /s/ Lonnie M. Smith<BR>
<HR align="right" size="1" width="97%" noshade>
Name: Lonnie M. Smith<BR>
Title: Chief Executive Officer</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Dated: April 24, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="003"></A></DIV>
<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><FONT size="1"><B>Exhibit</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><FONT size="1"><B>No.</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="left"><FONT size="1"><B>Description</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><HR size="1" width="35%" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="left"><HR size="1" width="8%" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">99.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Press Release, dated April&nbsp;24, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P align="center"><FONT size="2">&nbsp;</FONT>




</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>f89501exv99w1.txt
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<PAGE>
                                                                    EXHIBIT 99.1

  Taking surgical precision and technique beyond the limits of the human
hand.(TM)


FOR IMMEDIATE RELEASE           Contacts:  Ben Gong       408-523-2175
                                           Sarah Norton   408-523-2161

    INTUITIVE SURGICAL ANNOUNCES $19.2 MILLION FIRST QUARTER REVENUE, UP 33%

SUNNYVALE, CALIF. April 24, 2003 - Intuitive Surgical, Inc. (NASDAQ: ISRG), the
leader in operative surgical robotics, today reported sales of $19.2 million in
the first quarter of 2003, up 33% from $14.4 million in sales reported in the
first quarter of 2002. Higher sales were driven by continued recurring revenue
growth and additional DA VINCI(R) Surgical System unit shipments. First quarter
2003 recurring revenue totaled $5.4 million, up 103% over the prior year and up
$0.7 million sequentially from the fourth quarter of 2002. Intuitive shipped 14
DA VINCI(R) Surgical Systems during the first quarter 2003 compared to 13 during
the first quarter last year.

<TABLE>
<CAPTION>
                                Q103        Q102     INCREASE
                                ----        ----     --------
REVENUE ($MILLIONS)
-------------------
<S>                          <C>         <C>         <C>
Systems                      $   13.8    $   11.7    $   2.1
Instruments/Accessories      $    3.6    $    1.7    $   1.9
Service                      $    1.8    $    1.0    $   0.8
                             -------------------------------
                             $   19.2    $   14.4    $   4.8
SYSTEM POPULATION
Placements                       14          13          1
Cumulative Placements           163         102         61
</TABLE>

Gross margin for the first quarter of 2003 was 54.6%, compared with 47.9% for
the first quarter of 2002. Improved 2003 gross margin was driven by a higher DA
VINCI(R) Surgical System average selling price and lower product warranty costs.

Net loss for the first quarter 2003 was $2.3 million, or ($0.06) per share
compared to a net loss of $5.6 million, or ($0.15) per share during the first
quarter 2002. Intuitive used $5.8 million of cash during the first quarter,
ending the period with $45.0 million in cash, cash equivalents and short-term
investments.
<PAGE>
Commenting on the announcement, Lonnie Smith, President and CEO of Intuitive
Surgical said: "We are pleased with our continued revenue growth and recurring
revenue momentum. Our sequentially lower operating expenses and shrinking net
loss demonstrate our progress towards achieving profitability. We are pleased
with our momentum as we move forward with our plans to merge with Computer
Motion."

Intuitive Surgical and Computer Motion continue to expect to close the proposed
merger by the end of June 2003. Currently, planning for the post-merger
transition is underway and the companies expect to meet the estimated $18
million in annual operating pre-tax cost savings. The outlook for the combined
entity is to record between $110 and $130 million of 2003 revenue on a pro forma
basis. The companies are targeting profitability by the fourth quarter of 2003
for the combined entity, excluding amortization of intangible assets and
one-time charges associated with the merger. The companies are analyzing
possible post-merger plans to enhance the efficiency and productivity of a
merged company. While no final decisions have been made, the companies are
considering various post-merger opportunities including the consolidation of
manufacturing and administrative functions at corporate headquarters,
maintaining an engineering presence in existing locations, and creating a single
sales and service force to cost-effectively serve and support customers
world-wide.

The company will also announce these results at a conference call today at 1:30
PM PST. The dial-in numbers for this call are 877-909-3508 for U.S. calls and
484-630-4228 for international calls. The passcode is ISRG and the meeting
leader is Mr. Lonnie Smith. To access financial information that will be
discussed on the call, please visit Intuitive Surgical's website at
www.intuitivesurgical.com.

About the DA VINCI(R) Surgical System:

The DA VINCI(R) Surgical System consists of a surgeon's viewing and control
console having an integrated, high-performance INSITE(R) 3-D vision system, a
patient-side cart consisting of three robotic arms that position and precisely
maneuver endoscopic instruments and an endoscope, and a variety of articulating
ENDOWRIST(R) Instruments. By integrating computer-enhanced technology with
surgeons' technical skills, Intuitive believes that its System enables surgeons
to perform better surgery in a manner never before experienced. The DA VINCI(R)
Surgical System seamlessly and directly translates the surgeon's natural hand,
wrist and finger movements on instrument controls at the surgeon's console
outside the patient's body into corresponding micro-movements of the instrument
tips positioned inside the patient through small puncture incisions, or ports.

                                      # # #
<PAGE>
This news release contains forward-looking statements within the meaning of the
"safe harbor" provisions of the Private Securities Litigation Reform Act of
1995, including statements about future financial and operating results and
Intuitive Surgical's anticipated merger with Computer Motion. You can identify
these forward-looking statements when you see us using words such as "intends,"
"expects," "anticipates," "estimates" and other similar expressions. These
statements are based on current expectations and beliefs and are subject to a
number of risks, uncertainties and assumptions that could cause actual results
to differ materially from those described in the forward-looking statements.
Actual results could differ materially from those expressed or implied in any
forward-looking statements as a result of certain risks and uncertainties,
including, without limitation, competition and market acceptance of products;
ability to obtain regulatory approvals and third-party reimbursements; ability
to raise additional capital; non-consummation of the proposed merger; prior to
the closing of the proposed merger the businesses of Intuitive Surgical or
Computer Motion suffer due to uncertainty; that the parties are unable to
successfully execute their integration strategies, or achieve planned synergies;
and other factors described in the Securities and Exchange Commission reports
filed by Intuitive Surgical and Computer Motion, including their most recent
filings on Form 10-K. Intuitive Surgical and Computer Motion undertake no
obligation to publicly update any forward-looking statements for any reason,
even if new information becomes available or other events occur in the future.

In connection with Intuitive Surgical's proposed merger with Computer Motion,
Intuitive Surgical has filed a registration statement on Form S-4 containing a
joint proxy statement/prospectus and other relevant materials. INVESTORS AND
SECURITY HOLDERS OF INTUITIVE SURGICAL AND COMPUTER MOTION ARE URGED TO READ THE
JOINT PROXY STATEMENT/PROSPECTUS AND THE OTHER MATERIALS CONTAINED IN THE
REGISTRATION STATEMENT BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT
INTUITIVE SURGICAL, COMPUTER MOTION AND THE PROPOSED MERGER. The registration
statement and any other documents filed with the SEC by Intuitive Surgical or
Computer Motion may be obtained free of charge at the SEC's website at
www.sec.gov. In addition, investors and security holders may obtain free copies
of the documents filed with the SEC by Intuitive Surgical by directing a request
to Intuitive Surgical, Inc., 950 Kifer Road, Sunnyvale, CA 94086, Attn: Sarah
Norton. Investors and security holders may obtain free copies of the documents
filed with the SEC by Computer Motion by contacting Computer Motion, Inc., 130-B
Cremona Drive, Goleta, CA 93117, Attn: Dan Tamkin.

INTUITIVE(R), DA VINCI(R), INSITE(R), and ENDOWRIST(R) are registered trademarks
of Intuitive Surgical, Inc.
<PAGE>
                            INTUITIVE SURGICAL, INC.
                CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                                             3 MONTHS ENDED
                                                             --------------
                                                         3/31/03         3/31/02
                                                         -------         -------
<S>                                                     <C>             <C>
Sales                                                   $ 19,235        $ 14,409
Cost of sales                                              8,738           7,507
                                                        --------        --------
            Gross Margin                                  10,497           6,902
            Gross Margin %                                  54.6%           47.9%
Operating costs and expenses
            Selling, general and administrative           10,209           8,785
            Research and development                       3,423           4,232
                                                        --------        --------
                Total operating costs and expenses        13,632          13,017
Loss from operations                                      (3,135)         (6,115)
Interest income/(expense)                                    842             498
                                                        --------        --------
Net loss                                                $ (2,293)       $ (5,617)
                                                        ========        ========
Net loss per share - basic and diluted                  $  (0.06)       $  (0.15)
                                                        ========        ========
Shares used in computing basic and
            diluted net loss per common share             36,862          36,308
                                                        ========        ========
</TABLE>
<PAGE>
                            INTUITIVE SURGICAL, INC.
                           CONSOLIDATED BALANCE SHEETS
                                 (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                UNAUDITED
                                                                 03/31/03       12/31/02 *
                                                                 --------       ----------
<S>                                                            <C>             <C>
ASSETS
Current assets:
       Cash and cash equivalents                               $  22,774       $  17,607
       Short-term investments                                     22,235          33,232
       Accounts receivable, net                                   20,895          16,887
       Inventory, net                                              8,282           8,738
       Prepaid expenses                                            2,037           2,161
                                                               ---------       ---------
Total current assets                                              76,223          78,625
Net property, plant, equipment                                     9,823          10,388
Other assets                                                       3,370           2,568
                                                               ---------       ---------
Total assets                                                   $  89,416       $  91,581
                                                               =========       =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
       Accounts payable                                        $  10,142       $   9,282
       Accrued compensation and employee benefits                  2,225           4,666
       Warranty accrual                                            2,100           2,269
       Accrued liabilities                                         3,485           3,497
       Deferred revenue                                            6,140           4,838
       Current portion of long-term debt                           1,434           1,511
                                                               ---------       ---------
Total current liabilities                                         25,526          26,063

Long term liabilities                                              1,531           1,838
Stockholders' equity:
       Common stock                                                   37              36
       Additional paid-in capital, net of issuance costs         192,412         191,020
       Deferred compensation                                        (112)           (223)
       Accumulated deficit                                      (131,084)       (128,791)
       Accumulated other comprehensive income                      1,106           1,638
                                                               ---------       ---------
Total stockholders' equity                                        62,359          63,680
Total liabilities and stockholders' equity                     $  89,416       $  91,581
                                                               =========       =========
</TABLE>


* - Derived from the audited financial statements included in our annual report
on Form 10K for the year ended December 31, 2002 but does not include all of the
information and footnotes required by accounting principles generally accepted
in the United States for complete financial statements.

</TEXT>
</DOCUMENT>
</SUBMISSION>
